ARCHIVES

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

This article is from The Cancer Letter archive.

Vol. 32 No. 12 | December 25, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Elizabeth Miller Dies; Mihich Names Associate Director At RPMI; AACR Calls For Abstracts

October 23, 1987

ACS Awards Grants To Wisconsin, USC For Behavior Research

July 16, 1993

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

Cullen Credits Staff With Success Of STCP, Strong Prevention Program a NCI

May 19, 1989

Stop Cancer Promises $7 Mil. By End Of Year

October 12, 1990

“Realistic” Bypass Budget For 1983 asks $1.147Billion; Organ Site, Training, Control Would Get No Increases

September 18, 1981